ProfMichael O'Reilly
Associate Professor
Department of Medicine
Orcid identifier0000-0002-9108-9105 (opens in a new tab)
- Associate ProfessorDepartment of Medicine
- +35318093894 (Work)
RESEARCH OVERVIEW
Androgen excess; polycystic ovary syndrome; Reproductive Endocrinology; adrenal tumours
GRANTS
- FUNDED PROJECTICAT-2 Funding - Lauren Madden DoyleNational University of Ireland, Galway /NUIG13 Jul 2026 - 12 Jul 2029
- FUNDED PROJECTICAT-2 Funding - Lauren Madden DoyleHealth Research Board / HRB13 Jul 2026 - 12 Jul 2029
- FUNDED PROJECTSteroid metabolomics as a tool to predict progression to endometrial hyperplasia and carcinoma in women with polycystic ovary syndromeEnterprise Ireland23 Apr 2026 - 22 Apr 2028
- FUNDED PROJECTThe impact of weight loss induced by bariatric surgery on mineralocorticoid metabolism in men and women living with obesityIrish Endocrine Society31 Oct 2025 - 31 Oct 2028
- FUNDED PROJECTA multi-site, open-label, sequential-group, multiple-dose trial to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamic effects of Lu AG13909 in participants with congenital adrenal hyperplasiaIndustry - Sponsored Clinical Trial – Economic Activity17 Sep 2025 - 30 Jun 2027
- FUNDED PROJECTBAR11-oxy: The impact of weight loss induced by Bariatric Surgery on metabolism of classic and 11-oxygenated Androgens in men and women with obesitySociety for Endocrinology18 Jun 2025 - 31 Dec 2026
- FUNDED PROJECTStipend increase for non state-funded PhD scholarsRCSI1 Jan 2024 - 30 Sep 2029
- FUNDED PROJECTA Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Reducing Supraphysiologic Glucocorticoid Use in Adult Subjects with Classic Congenital Adrenal HyperplasiaIndustry24 Aug 2023 - 30 Nov 2027
- FUNDED PROJECTA Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Efficacy and Safety of SPR001 (Tildacerfont) in Adult Subjects with Classic Congenital Adrenal HyperplasiaIndustry24 Aug 2023 - 30 Nov 2027
- FUNDED PROJECTPRE-receptor activation and Metabolic Impact of 11-oXygenated androgens in polycystic ovary syndromeEnterprise Ireland20 Mar 2023 - 19 Mar 2025
- FUNDED PROJECTDevelopment of clinical and research capabilities, infrastructures and programmes.Industry - Cash1 Jan 2023 - 1 Aug 2024
- FUNDED PROJECTTip of the iceberg: highlighting the long term health consequences of polycystic ovary syndromeHealth Research Board / HRB5 Dec 2022 - 4 Dec 2023
- FUNDED PROJECTUtilising a 3d bioprinting model to dissect the impact of androgen excess on skeletal muscle energy metabolism in women with polycystic ovary syndromeRCSI30 Sep 2022 - 29 Sep 2024
- FUNDED PROJECTExploring the relationship between androgen metabolism, metabolic disease and body mass index in menRCSI11 Jul 2022 - 30 Sep 2025People funded by this grant:
- Brian O
- FUNDED PROJECTICAT Fellowship (Year 2-4) - Leanne CussenWellcome Trust11 Jul 2022 - 10 Nov 2025
- FUNDED PROJECTICAT Year 1 Fellowship - Leanne CussenWellcome Trust12 Jul 2021 - 11 Jul 2022
- FUNDED PROJECTLinking 11-oxygenated androgens, skeletal muscle glucose metabolism and diabetes risk in polycystic ovary syndromeHealth Research Board / HRB1 Oct 2020 - 30 Sep 2024